Global Cancer Test Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Cancer Test Revenue
• 1.4 Market by Type
  • 1.4.1 Global Cancer Test Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Laboratory Tests
  • 1.4.3 Genetic Tests
  • 1.4.4 Imaging
  • 1.4.5 Endoscopy
• 1.5 Market by Application
  • 1.5.1 Global Cancer Test Market Share by Application: 2020 VS 2026
  • 1.5.2 Bladder Cancer Test
  • 1.5.3 Breast Cancer Test
  • 1.5.4 Cervical Cancer Test
  • 1.5.5 Colorectal (Colon) Cancer Test
  • 1.5.6 Ovarian Cancer Test
  • 1.5.7 Prostate Cancer Test
  • 1.5.8 Liver Cancer Test
  • 1.5.9 Flow Cytometry
  • 1.5.10 Other Organ Specific Cancer Test
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Cancer Test Market Perspective (2015-2026)
• 2.2 Global Cancer Test Growth Trends by Regions
  • 2.2.1 Cancer Test Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Cancer Test Historic Market Share by Regions (2015-2020)
  • 2.2.3 Cancer Test Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Cancer Test Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Cancer Test Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Cancer Test Players by Market Size
  • 3.1.1 Global Top Cancer Test Players by Revenue (2015-2020)
  • 3.1.2 Global Cancer Test Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Cancer Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Cancer Test Market Concentration Ratio
  • 3.2.1 Global Cancer Test Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Cancer Test Revenue in 2019
• 3.3 Cancer Test Key Players Head office and Area Served
• 3.4 Key Players Cancer Test Product Solution and Service
• 3.5 Date of Enter into Cancer Test Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Cancer Test Historic Market Size by Type (2015-2020)
• 4.2 Global Cancer Test Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Cancer Test Market Size by Application (2015-2020)
• 5.2 Global Cancer Test Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Cancer Test Market Size (2015-2020)
• 6.2 Cancer Test Key Players in North America (2019-2020)
• 6.3 North America Cancer Test Market Size by Type (2015-2020)
• 6.4 North America Cancer Test Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Cancer Test Market Size (2015-2020)
• 7.2 Cancer Test Key Players in Europe (2019-2020)
• 7.3 Europe Cancer Test Market Size by Type (2015-2020)
• 7.4 Europe Cancer Test Market Size by Application (2015-2020)

8 China

• 8.1 China Cancer Test Market Size (2015-2020)
• 8.2 Cancer Test Key Players in China (2019-2020)
• 8.3 China Cancer Test Market Size by Type (2015-2020)
• 8.4 China Cancer Test Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Cancer Test Market Size (2015-2020)
• 9.2 Cancer Test Key Players in Japan (2019-2020)
• 9.3 Japan Cancer Test Market Size by Type (2015-2020)
• 9.4 Japan Cancer Test Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Cancer Test Market Size (2015-2020)
• 10.2 Cancer Test Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Cancer Test Market Size by Type (2015-2020)
• 10.4 Southeast Asia Cancer Test Market Size by Application (2015-2020)

11 India

• 11.1 India Cancer Test Market Size (2015-2020)
• 11.2 Cancer Test Key Players in India (2019-2020)
• 11.3 India Cancer Test Market Size by Type (2015-2020)
• 11.4 India Cancer Test Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Cancer Test Market Size (2015-2020)
• 12.2 Cancer Test Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Cancer Test Market Size by Type (2015-2020)
• 12.4 Central & South America Cancer Test Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Abbott
  • 13.1.1 Abbott Company Details
  • 13.1.2 Abbott Business Overview
  • 13.1.3 Abbott Cancer Test Introduction
  • 13.1.4 Abbott Revenue in Cancer Test Business (2015-2020))
  • 13.1.5 Abbott Recent Development
• 13.2 Radient Pharmaceuticals
  • 13.2.1 Radient Pharmaceuticals Company Details
  • 13.2.2 Radient Pharmaceuticals Business Overview
  • 13.2.3 Radient Pharmaceuticals Cancer Test Introduction
  • 13.2.4 Radient Pharmaceuticals Revenue in Cancer Test Business (2015-2020)
  • 13.2.5 Radient Pharmaceuticals Recent Development
• 13.3 BD Diagnostics
  • 13.3.1 BD Diagnostics Company Details
  • 13.3.2 BD Diagnostics Business Overview
  • 13.3.3 BD Diagnostics Cancer Test Introduction
  • 13.3.4 BD Diagnostics Revenue in Cancer Test Business (2015-2020)
  • 13.3.5 BD Diagnostics Recent Development
• 13.4 Beckman Coulter
  • 13.4.1 Beckman Coulter Company Details
  • 13.4.2 Beckman Coulter Business Overview
  • 13.4.3 Beckman Coulter Cancer Test Introduction
  • 13.4.4 Beckman Coulter Revenue in Cancer Test Business (2015-2020)
  • 13.4.5 Beckman Coulter Recent Development
• 13.5 BioCurex
  • 13.5.1 BioCurex Company Details
  • 13.5.2 BioCurex Business Overview
  • 13.5.3 BioCurex Cancer Test Introduction
  • 13.5.4 BioCurex Revenue in Cancer Test Business (2015-2020)
  • 13.5.5 BioCurex Recent Development
• 13.6 bioMerieux
  • 13.6.1 bioMerieux Company Details
  • 13.6.2 bioMerieux Business Overview
  • 13.6.3 bioMerieux Cancer Test Introduction
  • 13.6.4 bioMerieux Revenue in Cancer Test Business (2015-2020)
  • 13.6.5 bioMerieux Recent Development
• 13.7 Cepheid
  • 13.7.1 Cepheid Company Details
  • 13.7.2 Cepheid Business Overview
  • 13.7.3 Cepheid Cancer Test Introduction
  • 13.7.4 Cepheid Revenue in Cancer Test Business (2015-2020)
  • 13.7.5 Cepheid Recent Development
• 13.8 CytoCore
  • 13.8.1 CytoCore Company Details
  • 13.8.2 CytoCore Business Overview
  • 13.8.3 CytoCore Cancer Test Introduction
  • 13.8.4 CytoCore Revenue in Cancer Test Business (2015-2020)
  • 13.8.5 CytoCore Recent Development
• 13.9 DiagnoCure
  • 13.9.1 DiagnoCure Company Details
  • 13.9.2 DiagnoCure Business Overview
  • 13.9.3 DiagnoCure Cancer Test Introduction
  • 13.9.4 DiagnoCure Revenue in Cancer Test Business (2015-2020)
  • 13.9.5 DiagnoCure Recent Development
• 13.10 Gen-Probe
  • 13.10.1 Gen-Probe Company Details
  • 13.10.2 Gen-Probe Business Overview
  • 13.10.3 Gen-Probe Cancer Test Introduction
  • 13.10.4 Gen-Probe Revenue in Cancer Test Business (2015-2020)
  • 13.10.5 Gen-Probe Recent Development
• 13.11 Genomic Health
  • 10.11.1 Genomic Health Company Details
  • 10.11.2 Genomic Health Business Overview
  • 10.11.3 Genomic Health Cancer Test Introduction
  • 10.11.4 Genomic Health Revenue in Cancer Test Business (2015-2020)
  • 10.11.5 Genomic Health Recent Development
• 13.12 QIAGEN Marseille (Earlier Ipsogen)
  • 10.12.1 QIAGEN Marseille (Earlier Ipsogen) Company Details
  • 10.12.2 QIAGEN Marseille (Earlier Ipsogen) Business Overview
  • 10.12.3 QIAGEN Marseille (Earlier Ipsogen) Cancer Test Introduction
  • 10.12.4 QIAGEN Marseille (Earlier Ipsogen) Revenue in Cancer Test Business (2015-2020)
  • 10.12.5 QIAGEN Marseille (Earlier Ipsogen) Recent Development
• 13.13 Myriad Genetics
  • 10.13.1 Myriad Genetics Company Details
  • 10.13.2 Myriad Genetics Business Overview
  • 10.13.3 Myriad Genetics Cancer Test Introduction
  • 10.13.4 Myriad Genetics Revenue in Cancer Test Business (2015-2020)
  • 10.13.5 Myriad Genetics Recent Development
• 13.14 Panacea Pharmaceuticals
  • 10.14.1 Panacea Pharmaceuticals Company Details
  • 10.14.2 Panacea Pharmaceuticals Business Overview
  • 10.14.3 Panacea Pharmaceuticals Cancer Test Introduction
  • 10.14.4 Panacea Pharmaceuticals Revenue in Cancer Test Business (2015-2020)
  • 10.14.5 Panacea Pharmaceuticals Recent Development
• 13.15 Qiagen
  • 10.15.1 Qiagen Company Details
  • 10.15.2 Qiagen Business Overview
  • 10.15.3 Qiagen Cancer Test Introduction
  • 10.15.4 Qiagen Revenue in Cancer Test Business (2015-2020)
  • 10.15.5 Qiagen Recent Development
• 13.16 Siemens Heathcare Diagnostics
  • 10.16.1 Siemens Heathcare Diagnostics Company Details
  • 10.16.2 Siemens Heathcare Diagnostics Business Overview
  • 10.16.3 Siemens Heathcare Diagnostics Cancer Test Introduction
  • 10.16.4 Siemens Heathcare Diagnostics Revenue in Cancer Test Business (2015-2020)
  • 10.16.5 Siemens Heathcare Diagnostics Recent Development
• 13.17 Roche
  • 10.17.1 Roche Company Details
  • 10.17.2 Roche Business Overview
  • 10.17.3 Roche Cancer Test Introduction
  • 10.17.4 Roche Revenue in Cancer Test Business (2015-2020)
  • 10.17.5 Roche Recent Development
• 13.18 Roche(Ventana Medical Systems)
  • 10.18.1 Roche(Ventana Medical Systems) Company Details
  • 10.18.2 Roche(Ventana Medical Systems) Business Overview
  • 10.18.3 Roche(Ventana Medical Systems) Cancer Test Introduction
  • 10.18.4 Roche(Ventana Medical Systems) Revenue in Cancer Test Business (2015-2020)
  • 10.18.5 Roche(Ventana Medical Systems) Recent Development
• 13.19 Trovagene
  • 10.19.1 Trovagene Company Details
  • 10.19.2 Trovagene Business Overview
  • 10.19.3 Trovagene Cancer Test Introduction
  • 10.19.4 Trovagene Revenue in Cancer Test Business (2015-2020)
  • 10.19.5 Trovagene Recent Development
• 13.20 Vermillion
  • 10.20.1 Vermillion Company Details
  • 10.20.2 Vermillion Business Overview
  • 10.20.3 Vermillion Cancer Test Introduction
  • 10.20.4 Vermillion Revenue in Cancer Test Business (2015-2020)
  • 10.20.5 Vermillion Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer